These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vitamin D receptor activators upregulate and rescue podocalyxin expression in high glucose-treated human podocytes. Verouti SN; Tsilibary EC; Fragopoulou E; Iatrou C; Demopoulos CA; Charonis AS; Charonis SA; Drossopoulou GI Nephron Exp Nephrol; 2012; 122(1-2):36-50. PubMed ID: 23548800 [TBL] [Abstract][Full Text] [Related]
3. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. Sanchez-Niño MD; Bozic M; Córdoba-Lanús E; Valcheva P; Gracia O; Ibarz M; Fernandez E; Navarro-Gonzalez JF; Ortiz A; Valdivielso JM Am J Physiol Renal Physiol; 2012 Mar; 302(6):F647-57. PubMed ID: 22169009 [TBL] [Abstract][Full Text] [Related]
4. The Therapeutic Effect of Active Vitamin D Supplementation in Preventing the Progression of Diabetic Nephropathy in a Diabetic Mouse Model. Nakhoul N; Thawko T; Farber E; Dahan I; Tadmor H; Nakhoul R; Hanut A; Salameh G; Shagrawy I; Nakhoul F J Diabetes Res; 2020; 2020():7907605. PubMed ID: 33294462 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D prevents podocyte injury via regulation of macrophage M1/M2 phenotype in diabetic nephropathy rats. Zhang XL; Guo YF; Song ZX; Zhou M Endocrinology; 2014 Dec; 155(12):4939-50. PubMed ID: 25188527 [TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli. Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232 [TBL] [Abstract][Full Text] [Related]
7. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats. Zhang X; Song Z; Guo Y; Zhou M Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315 [TBL] [Abstract][Full Text] [Related]
8. Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes. Denhez B; Lizotte F; Guimond MO; Jones N; Takano T; Geraldes P J Biol Chem; 2015 Jan; 290(1):350-8. PubMed ID: 25404734 [TBL] [Abstract][Full Text] [Related]
9. The PI3K/p-Akt signaling pathway participates in calcitriol ameliorating podocyte injury in DN rats. Song Z; Guo Y; Zhou M; Zhang X Metabolism; 2014 Oct; 63(10):1324-33. PubMed ID: 25044177 [TBL] [Abstract][Full Text] [Related]
10. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes. Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease. Zhang X; Zhang L; Wen Y; Zhang M; Liu S; Xiao H Kidney Blood Press Res; 2023; 48(1):314-325. PubMed ID: 37054686 [TBL] [Abstract][Full Text] [Related]
12. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli. Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D/vitamin D receptor/Atg16L1 axis maintains podocyte autophagy and survival in diabetic kidney disease. Shi L; Xiao C; Zhang Y; Xia Y; Zha H; Zhu J; Song Z Ren Fail; 2022 Dec; 44(1):694-705. PubMed ID: 35469547 [TBL] [Abstract][Full Text] [Related]
14. Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3-K/Akt signalling. Ha TS; Hong EJ; Han GD Diabetes Metab Res Rev; 2015 Jan; 31(1):50-60. PubMed ID: 24846128 [TBL] [Abstract][Full Text] [Related]
15. Activation of vitamin D receptor attenuates high glucose-induced cellular injury partially dependent on CYP2J5 in murine renal tubule epithelial cell. Liu Y; Li L; Yi B; Hu ZX; Li AM; Yang C; Zheng L; Zhang H Life Sci; 2019 Oct; 234():116755. PubMed ID: 31415769 [TBL] [Abstract][Full Text] [Related]
16. HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy. Doublier S; Zennaro C; Spatola T; Lupia E; Bottelli A; Deregibus MC; Carraro M; Conaldi PG; Camussi G AIDS; 2007 Feb; 21(4):423-32. PubMed ID: 17301560 [TBL] [Abstract][Full Text] [Related]
17. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy. Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811 [TBL] [Abstract][Full Text] [Related]
18. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway. Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993 [TBL] [Abstract][Full Text] [Related]
19. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway. Kim DY; Kang MK; Lee EJ; Kim YH; Oh H; Kang YH Mol Nutr Food Res; 2018 Oct; 62(19):e1800302. PubMed ID: 29987888 [TBL] [Abstract][Full Text] [Related]
20. Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2α-ATF-CHOP pathway in diabetic mice. Kang MK; Park SH; Kim YH; Lee EJ; Antika LD; Kim DY; Choi YJ; Kang YH Acta Pharmacol Sin; 2017 Aug; 38(8):1129-1140. PubMed ID: 28502979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]